Why is Bajaj Healthcare falling/rising?

Recent Price Movement and Market Context

Bajaj Healthcare’s current price is perilously close to its 52-week low of ₹398, just 0.87% above this level, signalling persistent downward pressure. The stock underperformed its sector by 2.35% on the day, hitting an intraday low of ₹400.25, a 2.62% decline. Furthermore, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend in both short and long-term technical indicators.

Investor participation has also waned, with delivery volumes on 16 Dec falling by 38.13% compared to the five-day average, suggesting reduced buying interest. Despite the stock’s liquidity being sufficient for moderate trade sizes, the lack of robust demand has contributed to the price weakness.

Fundamental Performance: A Mixed Picture

On the positive side, Bajaj Healthcare reported strong quarterly results in September 2025. The company’s operating profit to interest ratio reached a high of 4.85 times, reflecting improved operational efficiency relative to its debt servicing costs. Profit after tax (PAT) surged by 77.8% to ₹13.50 crore, while PBDIT hit a record ₹26.94 crore. These figures underscore the company’s ability to generate higher profits in the near term.

Additionally, the company’s return on capital employed (ROCE) stands at a respectable 8.1%, and its enterprise value to capital employed ratio of 2.1 suggests an attractive valuation compared to peers. The stock trades at a discount relative to historical valuations of similar companies, and despite a negative one-year return of -14.41%, Bajaj Healthcare’s profits have increased by 52.1% over the same period. The PEG ratio of 0.8 further indicates that the stock may be undervalued based on earnings growth expectations.

Long-Term Challenges Weighing on the Stock

However, these positives are overshadowed by significant long-term concerns. The company has experienced a negative compound annual growth rate (CAGR) of -5.62% in operating profits over the past five years, signalling deteriorating core business performance. Bajaj Healthcare’s ability to service its debt is also questionable, with a high Debt to EBITDA ratio of 2.59 times, indicating elevated leverage and potential financial risk.

Moreover, the stock has consistently underperformed key benchmarks. Over the last one year, it generated a return of -14.41%, lagging behind the Sensex’s 4.80% gain. The underperformance extends to three-year and one-month periods, where the stock’s returns remain negative while the broader market indices have posted strong gains. This persistent lag reflects investor scepticism about the company’s growth prospects and financial health.

Investor Sentiment and Outlook

The majority shareholding by promoters suggests stable ownership, but this has not translated into positive momentum for the stock price. The combination of weak long-term fundamentals, high leverage, and consistent underperformance against benchmarks has dampened investor confidence. The recent decline in delivery volumes further indicates a lack of conviction among market participants.

While the company’s recent quarterly results and valuation metrics offer some encouragement, these factors have not been sufficient to offset concerns about its financial stability and growth trajectory. Consequently, Bajaj Healthcare’s shares continue to face selling pressure, reflected in the current downtrend and proximity to 52-week lows.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →